Delivery Order SPE2DB24D1205-SPE2DB25FCYBQ
Award Date
6/26/25
Potential Completion Date
6/27/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product, with a ceiling value of $5,520.08. The contract is a firm fixed-price delivery order contract with a period of performance that extends to July 2, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product, with a ceiling value of $2,760.70 and a completion date of July 3, 2025. The contract is firm fixed price and non-set-aside, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,494.76, is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EBGLYSS 250 MG/2 ML PEN 2ML, a medical product, with a firm fixed price of $7,369.62 and a completion date of May 13, 2025. The contract is not set aside and was awarded on May 12, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,534.57, is for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a pharmaceutical product, EBGLYSS 250 MG/2 ML PEN 2ML, with a firm fixed price of $1,819.44 and a completion date of June 25, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EBGLYSS 250 MG/2 ML PEN 2ML, a medical product, with a ceiling value of $1,675.09 and a performance period ending on May 28, 2025. The contract is not set-aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of EBGLYSS 250 MG/2 ML PEN 2ML medical products. The fixed-price delivery order, valued at $11,166.73, has a performance period through May 15, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of EBGLYSS 250 MG/2 ML PEN 2ML, a medical product, with a ceiling value of $2,747.38. The contract is a firm fixed price, delivery order type with a performance period ending on May 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a medication called EBGLYSS 250 MG/2 ML PEN 2ML. The contract has a ceiling value of $11,271.64 and is a firm-fixed-price delivery order, with a period of performance through July 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and there is no information provided...